Telik Downgraded
Telik Inc. (TELK) was downgraded after reporting disappointing drug trial results. Shares of the biopharmaceutical lost 36 cents to close at $4.41.
posted by FC Market News at 2:28 PM
Wednesday, December 27, 2006
Previous Posts
- Revenue Falls For Euro Tech
- FDA Approval For Vascular Solutions' Tool
- InfoSonics To Distribute Handsets
- Piper Jaffray Lifts Price Target For Guess?
- Sento Swings To Loss
- Zi Continues To Climb
- FDA To Review Cyberonics' Depression Treatment
- Anadarko Sells Fields To EXCO
- Acme Packet Hits New High
- Telik Reports Disappointing Test Results
0 Comments:
Post a Comment
<< Home